Robeco Institutional Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Robeco Institutional Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-27,006	Closed	-$899K	–	1005
2020 Q2	$899K	Buy	+27,006	New	+$860K	﹤0.01%	758
2018 Q2	–	Sell	-21,851	Closed	-$397K	–	997
2018 Q1	$397K	Hold	21,851	–	–	﹤0.01%	824
2017 Q4	$305K	Hold	21,851	–	–	﹤0.01%	805
2017 Q3	$404K	Hold	21,851	–	–	﹤0.01%	739
2017 Q2	$370K	Hold	21,851	–	–	﹤0.01%	771
2017 Q1	$292K	Buy	+21,851	New	+$342K	﹤0.01%	765

Other funds holding MNTA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Robeco Institutional Asset Management's MNTA Position: Q3 2020 in Review

Robeco Institutional Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 27,006 shares — an estimated $899K sold.

Robeco Institutional Asset Management first reported a position in MNTA in Q1 2017 and held it in 6 quarters. The position peaked at $899K in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

Robeco Institutional Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Robeco Institutional Asset Management sold 27,006 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $899K.
Robeco Institutional Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2017 and held it in 6 quarters.
Robeco Institutional Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $899K in Q2 2020.
211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Robeco Institutional Asset Management's 13F filing for Q3 2020, filed 29 Oct 2020.